T26	Exp 30 52	the interleukin-2 gene
T27	Exp 234 255	the active metabolite
T28	Exp 414 416	We
T29	Exp 526 528	it
T30	Exp 429 433	that
T31	Exp 521 525	that
T32	Exp 597 620	the vitamin D3 receptor
T33	Exp 628 630	We
T34	Exp 832 834	We
T35	Exp 1042 1047	which
T36	Exp 888 900	the receptor
T37	Exp 1223 1249	the VDR DNA-binding domain
T38	Exp 1272 1283	the element
T39	Exp 1181 1193	this element
T40	Exp 1351 1355	that
T41	Exp 1328 1341	These results
T42	Exp 1486 1488	we
T43	Exp 1498 1506	the loss
T44	Exp 1510 1591	the bound NFATp/AP-1-DNA complex upon inclusion of VDR or VDR-retinoid X receptor
T45	Exp 1645 1649	that
T46	Exp 1650 1689	the VDR-retinoid X receptor heterodimer
T47	Exp 1758 1777	the NF-AT-1 element
T48	Exp 1920 1923	how
T49	Exp 1865 1878	the IL-2 gene
T50	Exp 1779 1801	This direct inhibition
R5	Coref Anaphora:T29 Antecedent:T51
R6	Coref Anaphora:T36 Antecedent:T10
R7	Coref Anaphora:T35 Antecedent:T11
R8	Coref Anaphora:T39 Antecedent:T12
R9	Coref Anaphora:T38 Antecedent:T12
T1	Protein 34 47	interleukin-2
T2	Protein 89 94	NFATp
T3	Protein 308 321	interleukin 2
T4	Protein 323 327	IL-2
T5	Protein 578 582	IL-2
T6	Protein 601 620	vitamin D3 receptor
T7	Protein 622 625	VDR
T8	Protein 694 698	IL-2
T9	Protein 746 750	IL-2
T10	Protein 786 789	VDR
T11	Protein 1033 1040	NF-AT-1
T12	Protein 1100 1105	NFATp
T13	Protein 1127 1130	VDR
T14	Protein 1227 1230	VDR
T15	Protein 1311 1315	IL-2
T16	Protein 1371 1374	VDR
T17	Protein 1418 1422	IL-2
T18	Protein 1520 1525	NFATp
T19	Protein 1561 1564	VDR
T20	Protein 1568 1571	VDR
T21	Protein 1654 1657	VDR
T22	Protein 1697 1702	NFATp
T23	Protein 1762 1769	NF-AT-1
T24	Protein 1869 1873	IL-2
T51	Exp 485 508	cycloheximide resistant
